non-muscle invasive bladder cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: In this multicentre retrospective cohort study, we analyzed data from patients with NMIBC who underwent initial TUR-Bt at 4 Juntendo University Hospitals and Teikyo University Hospital between 2000 and 2013 (JT cohort). To achieve adequate pathological staging, the complete resection aimed to include the muscle layer of the bladder wall.
Exclusion criteria
Exclusion criteria: Patients with any of the following were excluded from this analysis: (i) non-Urothelial carcinoma histology, (ii) follow-up periods < 3 months: (iii) history of muscle-invasive or metastatic bladder cancer; (iv) history of carcinoma of the urethra, prostate (ducts or stroma), or upper urinary tract; (v) history of local radiation therapy to the pelvis; (vi) history of every kind of chemotherapy; (vii) history of previous bacillus Calmette-Guerin (BCG) therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrence free survival rate | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression disease, and death of bladder cancer | — |
Countries
Japan
Contacts
Juntendo University, Graduate School of Medicine Department of Urology